Childhood acute lymphoblastic leukemia (ALL) is a genetically and prognostically
heterogeneous malignancy with a mortality rate of 20%[1]. The identification of novel …

MicroRNAs (miRNAs/miRs) are promising prognostic biomarkers in pediatric acute
lymphoblastic leukemia (ALL). The present study aimed to identify miRNAs that could serve …

MicroRNA (miRNA) expression is reportedly associated with clinical outcomes in childhood
acute lymphoblastic leukemia (ALL). Here, we aimed at investigating whether miRNA …

Recent studies suggest abnormal microRNA (miRNA) expression may have potential
prognostic value in childhood acute lymphoblastic leukemia (ALL). In this systematic review …

Dysregulation of microRNA (miRNA) expression contributes to the pathogenesis of several
clinical conditions. The aim of this study is to evaluate the associations between miRNAs …

Several studies detected abnormal mi-RNAs expression levels in childhood Acute
Lymphoblastic Leukemia (ALL) with potential diagnostic value. We conducted a systematic …

Simple Summary MicroRNAs (miRNAs) have been under the spotlight for the last three
decades. These non-coding RNAs seem to be dynamic regulators of mRNA stability and …

Despite remarkable improvements in survival of childhood acute lymphoblastic leukemia
(ALL), nonresponding or relapsing patients still represent one of the most frequent causes of …

OncomiRs are microRNAs that are associated with early onset of specific cancers. To
identify microRNAs involved in pediatric acute lymphoblastic leukemia (ALL) subtypes T …

Acute lymphoblastic leukemia (ALL) is the most common type of pediatric neoplasia. Highly
heterogeneous, ALL includes several genetic subtypes with varying clinical outcome …